Inventor · disambiguated record
Ana Maria García Collazo
Also filed as: GARCIA COLLAZO ANA M · GARCIA COLLAZO ANA MARIA · GARCÍA COLLAZO ANA MARÍA · GARCÍA COLLAZO Ana Maria
9 granted patents·13 pending applications·28 citations·filing 2005–2023
82Inventor score
Files withMINORYX THERAPEUTICS S L11KAROBIO AB4GAIN THERAPEUTICS SA3PEVARELLO PAOLO2GARCIA COLLAZO ANA MARIA1
Top patents by PatentIndex Score
22 records- 0189US9782395B22,4-thiazolidinedione derivatives in the treatment of central nervous system disordersMINORYX THERAPEUTICS S L·Filed 2016·Granted Oct 10, 2017·13 cites·22 claims
- 0282US8563550B2Imidazolothiadiazoles for use as protein kinase inhibitorsPEVARELLO PAOLO·Filed 2008·Granted Oct 22, 2013·12 cites·22 claims
- 0377US10179126B22,4-thiazolidinedione derivatives in the treatment of central nervous system disordersMINORYX THERAPEUTICS S L·Filed 2017·Granted Jan 15, 2019·2 cites·26 claims
- 0473US11124505B2Process for preparing 5-[[4-[2-[5-(1-hydroxyethyl)-2-pyridinyl]ethoxy]phenyl]methyl]-2,4-thiazolidinedione and salts thereofMINORYX THERAPEUTICS S L·Filed 2017·Granted Sep 21, 2021·1 cites·63 claims
- 0568US2024091210A1Use of 5-[[4-[2-[5-acetylpyridin-2-yl]ethoxy]benzyl]-1,3-thiazolidine-2,4-dione and its saltsMINORYX THERAPEUTICS S L·Filed 2023·Application pending·0 cites
- 0665US11731963B2Process for preparing 5-[[4-[2-[5-(1-hydroxyethyl)-2-pyridinyl]ethoxy]phenyl]-methyl]-2,4-thiazolidinedione and salts thereofMINORYX THERAPEUTICS S L·Filed 2021·Granted Aug 22, 2023·0 cites·18 claims
- 0756US11739072B2Heteroaryl compounds and their useMINORYX THERAPEUTICS S L·Filed 2021·Granted Aug 29, 2023·0 cites·30 claims
- 0853US2019255032A12,4-Thiazolidinedione Derivatives in the Treatment of Central Nervous System DisordersMINORYX THERAPEUTICS S L·Filed 2018·Application pending·0 cites
- 0950US2021228558A1Use of 5-[[4-[2-[5-acetylpyridin-2-yl]ethoxy]benzyl]-1,3-thiazolidine-2,4-dione and its saltsMINORYX THERAPEUTICS S L·Filed 2019·Application pending·0 cites
- 1046US2023140216A1Combination therapy for treating mps1GAIN THERAPEUTICS SA·Filed 2021·Application pending·0 cites
- 1144US2011046127A1Imidazopyridazines for Use as Protein Kinase InhibitorsPEVARELLO PAOLO·Filed 2008·Application pending·0 cites
- 1244US2023058312A1Aryl and heteroaryl compounds, and therapeutic uses thereof in conditions associated with the alteration of the activity of galactocerebrosidaseGAIN THERAPEUTICS SA·Filed 2020·Application pending·0 cites
- 1343US2023107499A1Heteroaryl compounds and therapeutic uses thereof in conditions associated with the alteration of the activity of beta-glucocerebrosidaseGAIN THERAPEUTICS SA·Filed 2020·Application pending·0 cites
- 1441US11174242B2Heteroaryl compounds and their useMINORYX THERAPEUTICS S L·Filed 2017·Granted Nov 16, 2021·0 cites·28 claims
- 1538US2016168132A1Di(hetero)arylamides and sulfonamides, methods for their preparation and therapeutic uses thereofMINORYX THERAPEUTICS S L·Filed 2014·Application pending·0 cites
- 1638US2010004271A1Heterocyclic compounds as aganist for the thyroid receptorKAROBIO AB·Filed 2006·Application pending·0 cites
- 1737US2009318514A1Novel Pharmaceutical CompositionsGARCIA COLLAZO ANA MARIA·Filed 2007·Application pending·0 cites
- 1836US11440898B2Isoquinoline compounds, methods for their preparation, and therapeutic uses thereof in conditions associated with the alteration of the activity of beta galactosidaseMINORYX THERAPEUTICS S L·Filed 2017·Granted Sep 13, 2022·0 cites·23 claims
- 1936US2008004251A1Novel Pharmaceutical Compositions Comprising Agonists of the Thyroid ReceptorKAROBIO AB·Filed 2005·Application pending·0 cites
- 2035US2008221210A1Thyroid Receptor AgonistsKAROBIO AB·Filed 2005·Application pending·0 cites
- 2134US2009233979A1Indole Derivatives and Their Use as Thyroid Receptor LigandsKAROBIO AB·Filed 2007·Application pending·0 cites
- 2219US9682991B2Tricyclic compounds for use as kinase inhibitorsPASTOR FERNÁNDEZ JOAQUÍN·Filed 2010·Granted Jun 20, 2017·0 cites·12 claims
Join the waitlist — get patent alerts
Get an alert when Ana Maria García Collazo files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →